Edaravone Dexborneol for Treatment of Acute Ischemic Stroke With Endovascular Therapy in Extended Time Windows
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT04817527
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Registry
-
NCT04817527
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04817527. Randomized; single masking; primary purpose treatment. Start 2021-10-01 (actual); primary completion 2022-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Edaravone Dexborneol for Treatment of Acute Ischemic Stroke With Endovascular Therapy in Extended Time Windows
- Acronym
- EXISTENT
- Condition
- Stroke, Ischemic
- Intervention (Drug)
- Edaravone Dexborneol
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
Record details
- Record id
cardio:ct-nct04817527- Content hash
805b84e1b631570cbdb276224c80a938b169c5f3f55789a07fd9e6bdcb92dc46